A-Share Pre-Market Brief | 2026-09-30 (Wednesday)

Time window: After the close on 2026-09-29 (Tuesday) 15:00 → pre-market 2026-09-30. Today is the last trading day before the National Day holiday; cross-quarter liquidity is worry-free (see Section 1), but cash-holding holiday selling pressure plus long-holiday external uncertainty (Micron earnings, US-Iran, US Treasury yields) stack up, and volume will very likely shrink further. Data scope: Overnight US stocks are the 9/29 (US Eastern Tuesday) close; individual stock quotes are the 9/29 A-share close (Tencent quotes); fundamental data comes from company periodic reports and 9/29 evening announcements (see Sections 4 and 5). Price limits: main board ±10%｜ChiNext/STAR ±20%｜BSE ±30%; all stocks below are labeled by board, and limit-up determination follows the respective board's limit. External backdrop: The three major US indexes closed slightly lower overnight (Dow -0.26%, S&P -0.17%, Nasdaq -0.09%), but the memory chain strengthened against the trend (SK Hynix +2%, Micron +1%; Micron reports after tonight's close); Brent crude fell sharply 2.56% to USD 102.59; FTSE A50 night session +0.15% at 13,900 points; offshore RMB edged up — neutral for today's open, no incremental panic.

---

0. Today's One-Line Summary

On the last pre-holiday trading day, the strongest pre-market catalyst is announcement-grade real money: 迪哲医药-U (Dizal Pharma, 688192, STAR) announced it has received the US$600 million upfront payment from AstraZeneca (global license of 舒沃哲; total deal value US$1.5 billion + sales royalty), roughly RMB 4.3 billion, about 1/6 of its current market cap — an S/A-grade "loss-making innovative drug refilled overnight" event. The property chain has policy-announcement resonance: after the three ministries' ready-built-housing rule and Shanghai's implementation rules landed yesterday, 滨江集团 (Binjiang Group, 002244, main board) announced overnight it won Hangzhou + Shanghai plots totaling ~RMB 8.28 billion; the branch enters day 2 of fermentation and today's divergence test. On the overseas industry side, OpenAI released at this morning's DevDay the personal AI agent "dots" with ChatGPT built in (GPT-6 Astra powered), escalating the AI agent race; combined with 网宿科技 (Wangsu Science & Technology, 300017, ChiNext) investing RMB 300 million in video-generation model Sand.ai, this provides a sentiment catalyst (mapping-grade) for AI applications / edge-side directions. Driver types: innovative drugs going global · property policy · overseas AI industry · announcement buybacks. Pre-market state read: yesterday saw a weak volume-shrinking repair (57 limit-ups / 10 limit-downs); today volume typically shrinks further; the main script is divergence and differentiation in the new mainlines (property / innovative drugs / solid-state) while old mainlines (tankers / robots) keep clearing — the auction sets the strength; don't chase volume-shrinking one-way boards.

---

1. News Overview

Slow-variable watch: ① Micron earnings (early 10/1 Beijing time) — the biggest external variable for the memory/compute chain over the long holiday; overnight SK Hynix +2% warmed up first; ② US Treasury 10Y/30Y yields (the master gate for high-PE growth; overnight US tech mostly still fell); ③ September official PMI (today 09:30, the same moment as the open); ④ US-Iran talks progress during the holiday (oil already fell 2.6% first; the tanker chain's reverse risk is unresolved); ⑤ 10/1 Huawei Mate90 launch and Qiyuan robot going on sale (post-holiday consumer / robot narrative).

---

2. Strongest Bullish Branches in Descending Order

Branch dictionary for the whole report: innovative drugs going global ｜ property chain (policy) ｜ AI agents / AI applications (overseas mapping) ｜ compute PCB / earnings-type compute ｜ lithium going global / solid-state batteries ｜ auto OEMs (restructuring) ｜ publishing/media (high-leader cluster) ｜ memory (earnings eve). Each stock belongs to exactly one branch; Sections 3/7 are consistent with this section.

Branch notes:

• Innovative drugs going global (No. 1): Why bullish — the US$600 million upfront (≈RMB 4.3 billion) is cash already received, equal to ~1/6 of Dizal's current market cap (~RMB 26 billion) and 2.5x its cash-like assets (~RMB 1.74 billion); it directly rewrites cash and current P&L at the statement level; 舒沃哲 (sunvozertinib) is approved in both China and the US, with the first-line indication's FDA application accepted, plus up to US$900 million milestones + sales royalty to follow. Short-term or mid-term: the news is event-driven, priced short-term over 1-3 days; mid-term depends on milestone delivery and the proprietary pipeline taking over. Realization path: the upfront is already realized; milestones realize along clinical / approval / sales nodes. Is it fully expected: the agreement was signed in July and took effect at end-August, so the market knew the framework — but the "US$600 million received" announcement came after the 9/29 close, and 9/30 is the first trading day, leaving pricing room. One-day-pop risk: medium-low — announcement-grade, large amount, but STAR ±20% amplifies swings. Branch composition: single-stock event, no cohort.
• Property chain (No. 2): Why bullish — the three ministries' "ready-built sales + pre-sale topping-out" rule is a nationwide sales-regime-level rule, with Shanghai's implementation rules the same day; the policy tier is above local loosening; Binjiang's overnight RMB 8.28 billion land announcement is physical validation of "policy tailwind → developers dare to buy land." Short-term or mid-term: policy game is 1 week short-term; mid-term fundamentals repair is doubtful. Realization path: sales → settlement → profit, a long chain; currently only at the "expectation" stage. Is it fully expected: the September property index already rose +1.46% against the market, and yesterday's limit-up wave (Vanke / Cinda / Hualian / Huafa / Binjiang + Shenzhen Property 2 boards) priced in a round — today is the divergence test day. One-day-pop risk: medium-high for high leaders (Shenzhen Property 2 boards, Capital Development touched the board), lower for the bellwether (Vanke sealed with RMB 2.2 billion). Branch composition: all main board.
• AI agents / applications (No. 3): dots is a landmark launch of the "resident personal agent" category (invocable by phone / SMS), more significant as competition signaling than direct earnings; on the A-share side, Wangsu's RMB 300 million into Sand.ai is a real announcement but the amount is only 4% of its cash-like assets. Mapping tiers: industry-trend positive (agents) / supply-chain indirect positive (compute) / pure concept mapping (A-share application software) coexist, ranked in that order.
• Compute PCB (No. 4): yesterday's 8 PCB limit-ups validated the "earnings anchor" logic, but there is no consecutive-board height; tonight's Micron earnings is the steering wheel for branch sentiment.
• Lithium / solid-state (No. 5): Gotion (announcement-grade; own H1 net profit attributable to parent +278%) and Shangshui Intelligent (theme-grade; H1 net profit -76%) must be priced separately — the latter has big elasticity but distant realization.
• Auto restructuring (No. 6): today watch only one thing — GAC's absorption on opening. Observe only, no re-entry.
• Publishing / media (No. 7): the company itself flags a 209x PE; the high-leader cluster enters the "faith stage"; use it as a sentiment wind vane only.
• Memory (No. 8): betting on the last pre-holiday night has poor odds; observe only.

---

3. Stock Benefit-Strength Leaderboard (by total score descending; ties share a rank)

---

4. Stock Scoring Model (total 100, one-to-one with Section 3 total scores)

---

5. Top 10 Stock Detailed Analysis

1迪哲医药-U688192Grade A | priority deep-dive · Dizal Pharma · STAR ±20%

• Related news: Announced evening 9/29: the company has recently received the US$600 million upfront payment from AstraZeneca for the global exclusive license of 舒沃哲 (sunvozertinib); the agreement also includes clinical development + sales milestones of up to US$900 million and tiered royalties on global sales, total deal value US$1.5 billion (Announcement Express (Sina)¹, Yicai²). The agreement was signed 7/14 and took effect 8/31.
• Bull logic: Direct and already realized — the upfront of ≈RMB 4.3 billion equals about 1/6 of the current market cap (RMB 25.97 billion) and 2.5x the cash-like assets at end-2026H1 (~RMB 1.74 billion); for a still-loss-making innovative drug company, this is a qualitative change in cash flow, and the one-off gain is likely to show up directly in the Q3 report (recognition subject to the quarterly report).
• Industry branch stage: an independent innovative-drug going-global event with no limit-up cohort; the comparable narrative is the "license-out" re-rating of domestic innovative drugs over the past two years (百利天恒 (Baili Tianheng) / 科伦博泰 (Kelun-Biotech) type).
• Fundamental check: 2025A revenue RMB 801 million (+122.6%), net profit attributable to parent -RMB 764 million (narrowed 9.7%); 2026H1 revenue RMB 523 million (+47.2%), net profit attributable to parent -RMB 210 million (loss narrowed 44.3%), gross margin 96%, operating cash flow -RMB 274 million, debt ratio 60.35%. Sunvozertinib: approved in both China and the US for second-line and later EGFR exon20 insertion NSCLC; first-line Phase III met its primary endpoint (2026 ASCO LBA, NEJM), first-line sNDA accepted by the FDA (8/30). Cash on hand RMB 179 million + trading financial assets RMB 1,557 million ≈ RMB 1.74 billion.
• Industry position: an AstraZeneca-incubated innovative drug platform; the "selling young crops" model — future value depends on the proprietary pipeline (DZD8586/DZD6008) taking over.
• Technicals / sentiment: STAR ±20%; only +0.61% all day on 9/29 (announcement came after the close) — the market has not yet priced the "cash received"; today's auction and the first 30 minutes are the pricing window. A gap-up above 15% — beware profit-taking; a flat or small gap-up with volume absorption is better.
• Final call: priority deep-dive. Biggest risks: accounting treatment of the upfront (one-off vs. installments), Q3 report recognition pace, and the lack of cohort relay after a "single pipeline event"; if the auction pins it straight to a one-way board, there is no entry point.

2滨江集团002244Grade A- | priority deep-dive · Binjiang Group · main board

• Related news: Announced evening 9/29: the wholly-owned subsidiary won Hangzhou residential land (RMB 1.865 billion) + two plots in the Gumei North Community, Minhang, Shanghai (consortium RMB 6.416 billion), totaling ~RMB 8.28 billion; the backdrop is the three ministries' 9/29 ready-built-housing rule + Shanghai implementation rules (policy continuation) (Announcement Express (Sina)¹, Caixin³).
• Bull logic: Direct — counter-cyclical land bank replenishment in core cities during the policy tailwind, locking in 2-3 years of future saleable value; the land purchase itself is the physical signal of "policy bottom → developers dare to buy land," lifting sector sentiment.
• Industry branch stage: the property chain is fermenting on day 2; yesterday Vanke / Cinda / Hualian / Huafa hit limit-up + Shenzhen Property made 2 boards; today is the divergence test.
• Fundamental check: limit-up close of RMB 9.46 on 9/29, market cap RMB 29.4 billion; 2025A revenue RMB 82.89 billion (+19.9%), net profit attributable to parent RMB 2.12 billion (-16.9%); 2026H1 revenue RMB 32.11 billion (-29.3%), net profit attributable to parent RMB 1.55 billion (-16.3%), operating cash flow +RMB 5.54 billion (+161.7%), debt ratio 72.4%, net assets attributable to parent RMB 30.69 billion; PB 0.96. 2026H1 full-caliber sales of RMB 43.15 billion, CRIC national No. 9, No. 1 among private developers; full-year target cut from RMB 100 billion to RMB 80 billion (54% completion); average financing cost 2.8%; cash on the books RMB 30.46 billion.
• Industry position: the "survivor + front-runner" of private developers by credit and operations; the hardest fundamentals in the property chain.
• Technicals / sentiment: main board ±10%, limit-up yesterday; the September property index rose +1.46% against the market, giving a trend backdrop; watch absorption amid today's sector divergence.
• Final call: priority deep-dive (top pick in the property chain). Biggest risks: net profit declining for consecutive periods (settlement margins falling) and sector beta not reversed — it is "the least bad in the sector," not "an industry reversal"; if the auction opens below -2% and Vanke shows no premium, downgrade the whole branch.

3广汽集团601238Grade A- | watch only (wind vane) · GAC Group · main board

• Related news: Plan disclosed evening 9/28 to issue shares to buy 50% of FAW Toyota equity (issue price RMB 5.75); one-way limit-up on resumption 9/29 (sealed at 09:25, turnover 0.11%, sealed orders RMB 352 million, never opened all day).
• Bull logic: Direct (injecting 50% of FAW Toyota profits); the target's 2025 net profit was ~RMB 4.23 billion and 2026H1 ~RMB 1.01 billion (unaudited); a below-book (PB 0.52) SOE restructuring.
• Industry branch stage: fermenting, but follow-through is weak (JAC +3.25% not advancing; only Xiangyang Bearing's 3 boards and Xuelong Group's 4 boards hold the cohort).
• Fundamental check: suspension price RMB 5.09, market cap RMB 51.9 billion; 2025A revenue RMB 96.54 billion (-10.4%), net profit attributable to parent -RMB 8.78 billion; 2026H1 net profit attributable to parent -RMB 4.47 billion (loss widened 76%), operating cash flow -RMB 7.1 billion, debt ratio 55%.
• Technicals / sentiment: main board ±10%, after consecutive one-way boards, opening today is highly likely; the absorption volume on opening and the re-seal speed = the sentiment ceiling of the auto chain.
• Final call: watch only (yesterday's recap verdict "observe, no re-entry" unchanged). Joining the opening-day game has poor odds: most of the catch-up was priced into the first one-way board, and relaying on a divergence day easily leaves you standing guard; just watch the auction sealed orders and cancellations as the branch wind vane.

4芯联集成688469Grade B+ | watch closely · Xinlian IC · STAR ±20%

• Related news: Earnings forecast on the evening of 9/28 (first-three-quarters net profit attributable to parent ~RMB 681 million turnaround, revenue +43.2%), +4.65% on 9/29 with RMB 2.4 billion of volume, no limit-up (old news re-fermenting, noted).
• Bull logic: Already realizing — Q3 single-quarter net profit attributable to parent ~RMB 400 million inflection; capacity utilization + gross margin (H1 12.7%) both rising; operating cash flow +RMB 1.27 billion.
• Industry branch stage: foundry independent of the memory ebb, trending; no limit-up cohort.
• Fundamental check: market cap RMB 72.1 billion; 2026H1 net profit attributable to parent +RMB 278 million (+263%), H1 ex-non-recurring still -RMB 65 million, PB 5.4x, not cheap.
• Technicals / sentiment: STAR ±20%, -8% over 60 days at a low, resilient yesterday; a trend-type target; don't chase a gap-up above 8%.
• Final call: watch closely. Highest earnings-realization certainty among the candidates, but no new news and it already bounced yesterday; today watch whether volume can continue; risks lie in the ex-non-recurring loss and valuation.

5国轩高科002074Grade B+ | watch closely · Gotion High-tech · main board

• Related news: Announced evening 9/28 plans to set up 3 overseas JVs with Volkswagen PowerCo (total investment ~EUR 3.222 billion), limit-up on 9/29 (09:37 turnover board); Dragon-Tiger: Guotai Haitong Taiping South Road bought RMB 212 million; also drove the solid-state battery branch (Jinlongyu / Shanghai Xiba / Veken Technology limit-up) (Cailianshe¹³).
• Bull logic: Indirect but large-scale (EUR 3.222 billion ≈ half the market cap); short-term it shows up as capex, with EPC revenue coming first.
• Industry branch stage: lithium going global + solid-state dual drive, fermenting day 2, today 1→2.
• Fundamental check: market cap RMB 47.3 billion; 2025A revenue RMB 45.07 billion (+27.4%), net profit attributable to parent RMB 2.38 billion (+97.5%); 2026H1 revenue RMB 27.78 billion (+43.2%), net profit attributable to parent RMB 1.39 billion (+278%), gross margin 15.6%; debt ratio 71.7%.
• Technicals / sentiment: main board ±10%, 1 board; today's auction premium after yesterday's limit-up decides the branch's height.
• Final call: watch closely. Announcement-grade positive + own earnings as support, but already limit-up yesterday; today's relay is a "strong stays strong" game; beware profit-taking on a gap-up above 5%, and watch absorption on a flat open. Risks: debt ratio and large-capex financing pressure.

6生益电子688183Grade B+ | watch closely · Shengyi Electronics · STAR ±20%

• Related news: Announced evening 9/28 a RMB 1.1 billion capital increase into the Ji'an high-multilayer compute-board project, +4.28% on 9/29; 8 PCB limit-ups in the sector yesterday (Xunjiexing 20cm, Aoshikang / Suntak etc.).
• Bull logic: An execution announcement of already-planned expansion; AI server boards are tight; capacity ramp = revenue visibility.
• Industry branch stage: compute PCB repair → fermenting; no consecutive-board height; the branch plays the "earnings anchor" role.
• Fundamental check: market cap RMB 91.2 billion; 2026H1 revenue RMB 5.78 billion (+53.5%), net profit attributable to parent RMB 1.11 billion (+109.4%), gross margin 34.3%, operating cash flow +RMB 920 million; PE (TTM) 44x, recovering after a -19% pullback over the past 20 days.
• Technicals / sentiment: STAR ±20%, repaired with yesterday's PCB limit-up wave; tonight's Micron earnings sets the sector's direction.
• Final call: watch closely. Core earnings-type compute holding, but valuation and the rate environment press; don't chase highs; a flat open stabilizing or a green flip from flat is a healthy tape.

7网宿科技300017Grade B | watch closely · Wangsu · ChiNext ±20%

• Related news: Announced evening 9/29 plans to invest RMB 300 million in Sand.ai (a video-generation model company) for Series A+ preferred shares, a 4.3963% stake; OpenAI DevDay released the personal agent dots this morning (Securities Times⁶, dots launch⁴).
• Bull logic: Indirect (sentiment mapping) — the RMB 300 million investment is only ~4% of its cash-like assets and 0.8% of market cap, a small financial impact; the point is the "CDN cash cow crossing into AI applications" narrative, and the dots launch reinforces agent / video-generation theme sentiment.
• Industry branch stage: the AI application theme pulses repeatedly in an ebb phase; no cohort.
• Fundamental check: closed RMB 14.69 on 9/29 (-0.47%), market cap RMB 36.7 billion; 2025A revenue RMB 4.66 billion (-5.5%), net profit attributable to parent RMB 800 million (+18.5%); 2026H1 revenue RMB 2.32 billion (-1.4%), net profit attributable to parent RMB 350 million (-6.6%); cash-like ~RMB 7.2 billion, debt ratio only 11.8%; PE (TTM) 47x. History note: a RMB 623 million CDNetworks goodwill impairment in 2019, and a 160x-premium acquisition of 创而新 (Chuang Er Xin) in 2020 that drew regulatory inquiries — a poor cross-border investment record.
• Industry position: second-tier CDN, transforming toward security / edge computing.
• Technicals / sentiment: ChiNext ±20%, -0.47% yesterday unmoved = unpriced; prone to impulse on the news.
• Final call: watch closely (accumulate on dips only, never chase). Small amount, stagnant main business; the participation value lies in "low position + thick cash + theme catalyst"; beware a one-day pop if the auction gaps up above 10%.

8万科A000002Grade B | watch closely (bellwether) · Vanke A · main board

• Related news: Limit-up on 9/29 (sealed capital RMB 2.2 billion, the biggest bellwether in the market); catalysts: the State Council executive meeting "studying the introduction of measures to stabilize the real estate market" + the three-ministry rule + Shanghai implementation rules; Dragon-Tiger: Shenzhen Connect bought RMB 119 million / sold RMB 59.48 million, institutions net sold RMB 29.2 million, northbound net bought RMB 60 million (Cailianshe¹⁴, NetEase¹⁵).
• Bull logic: Sentiment-led — the policy-game bellwether; the market narrative is "Shenzhen Metro blood transfusion + bond extension + policy bottom"; not a fundamentals reversal.
• Industry branch stage: the property chain bellwether; the branch's strength depends on it.
• Fundamental check: limit-up close of RMB 4.08, market cap RMB 48.7 billion; 2025A revenue RMB 233.4 billion (-32%), net profit attributable to parent -RMB 88.56 billion; 2026H1 revenue RMB 70.17 billion (-33.4%), net profit attributable to parent -RMB 14.95 billion (verified consistent with the periodic report), operating cash flow +RMB 495 million (turned positive), debt ratio 77.5%, interest-bearing debt due within one year ~RMB 154 billion vs RMB 59 billion cash, Shenzhen Metro loan balance RMB 34.1 billion; PB 0.48.
• Industry position: the "living flag" of the property industry; Shenzhen Metro is the largest shareholder.
• Technicals / sentiment: main board ±10%; RMB 2.2 billion of sealed capital shows capital consensus, but institutional seats are selling = divergence already visible; today's auction premium and opening absorption are the property chain's barometer.
• Final call: watch closely (bellwether, not a buy recommendation). It decides branch sentiment rather than its own odds; the Dragon-Tiger "institutions selling / northbound buying" signals divergence; if it opens lower with no premium today, that is a cooling signal for the policy game. Fundamentally, ~RMB 150 billion of debt maturing within a year is a hard wound; use it as a sentiment indicator only.

9中国出版601949Grade C+ | watch only · China Publishing & Media · main board

• Related news: Publishing/media high-leader cluster expansion (Xinhua Media leading with 6 boards), 9/29 limit-up as the bellwether; two unusual-movement announcements (risk warnings) already on 9/4 and 9/7.
• Bull logic: Pure sentiment — sector follow-through driven by the high leaders, with no catalyst of its own.
• Industry branch stage: fermenting day 2 (high-leader driven); the risk lies in Xinhua Media's sealed orders.
• Fundamental check: close of RMB 6.01, market cap RMB 11.4 billion; 2025A revenue RMB 5.33 billion (-12.8%), net profit attributable to parent RMB 647 million (+0.5%); 2026H1 revenue RMB 1.92 billion (-8.6%), net profit attributable to parent RMB 15 million (-88.4%), ex-non-recurring -RMB 59.61 million (turned to loss); debt ratio 32%; PE (TTM) 21.6x (profit padded by subsidies).
• Technicals / sentiment: main board ±10%, follow-through limit-up; it falls when the high leader breaks.
• Final call: watch only. The branch's strength is read only from Xinhua Media's sealed orders; don't touch follow-through stocks.

10尚水智能301513Grade C+ | watch only · Shangshui Intelligent · ChiNext ±20%

• Related news: Solid-state battery equipment imagination, 20cm limit-up on 9/29 (verified against Tencent K-line as the first 20cm board: 9/28 closed RMB 42.85 -3.95%, 9/29 closed RMB 51.42 +20%); some market recaps called it "2 consecutive boards" — the K-line prevails.
• Bull logic: Theme mapping — the company says its semi-dry / dry electrode equipment is "in small-batch delivery to the CAS Institute of Physics, BYD, Yinpai Battery etc., used in solid-state battery R&D manufacturing and production testing," with no mass-production-grade solid-state order announcement; orders on hand ~RMB 2.2 billion (2026/4 IR-interactive platform caliber).
• Industry branch stage: a solid-state battery theme elasticity target, not the leader (Gotion is the branch core).
• Fundamental check: market cap RMB 5.14 billion (total shares of only 100 million); 2025A revenue RMB 804 million (+26.2%), net profit attributable to parent RMB 156 million (+245%), gross margin 43.1%; 2026H1 revenue RMB 630 million (+58.4%), net profit attributable to parent RMB 22 million (-76.2%), gross margin halved to 21.6% (new products cutting into the low-price coating red sea at low prices); operating cash flow +RMB 352 million; PE (TTM) 60.6x. ~60% share of the lithium battery slurry-equipment niche, ranking first; BYD is the largest customer and a 7.69% shareholder; listed on ChiNext on 2026/4/17 (newly listed stock).
• Technicals / sentiment: ChiNext ±20%, 20cm elasticity + newly listed attribute, a sentiment amplifier.
• Final call: watch only. The solid-state narrative is real, the earnings realization is fake (revenue up without profit); 60x PE is pure sentiment pricing; 20cm swings are violent — terrible odds for chasing highs.

---

6. Pass List

---

7. Intra-Branch Ranking

Property chain (policy, today's strongest branch)

Innovative drugs going global

AI agents / AI applications (overseas mapping)

Compute PCB / earnings-type compute

Lithium going global / solid-state batteries

Auto OEMs (restructuring)

Publishing / media

---

8. Opening Verification Signals Today

• Auction signals (9:15-9:25):
  • Dizal Pharma (迪哲医药, 688192): sealed orders / gap-up magnitude — a gap-up of 5-10% with mild auction volume = healthy pricing; above 15% beware profit-taking; a flat open = below expectations, skip the innovative-drug branch for the day;
  • Vanke A (万科 A, 000002) / Binjiang Group (滨江集团, 002244): does Vanke have an auction premium (a flat open = policy game cooling); a Binjiang gap-up of 2-5% is healthy;
  • GAC Group (广汽集团, 601238): sealed order size vs yesterday's RMB 352 million; cancellations after 9:20 = degree of divergence; re-seal speed after opening;
  • Xinhua Media (新华传媒, 600825): are sealed orders loosening — loosening = media sector ebb signal;
  • Gotion High-tech (国轩高科, 002074): auction premium and volume ratio, willingness for 1→2;
  • Xinlian IC / Shengyi Electronics: flat to small gap-up = good absorption; don't chase above 8%.
• Sector signals: 3+ quick property limit-ups = divergence turning to consensus; can PCB produce its first consecutive board (decides the compute branch's status); lithium watches whether Gotion makes 2 boards + a second solid-state limit-up appears; innovative drugs watch for follow-through beyond Dizal (Hengrui / BeiGene-type license-out mapping).
• Stock signals: first-5-minute absorption volume; whether big-order net inflow goes to "announcement + earnings" names (Dizal / Binjiang / Xinlian) rather than pure themes; 20cm target (Shangshui) sealed-order quality.
• Risk signals (cut positions / remove from watch on sight): index opening lower and going lower; yesterday's strong stocks (Vanke / Shenzhen Property / Xinhua Media) correcting together; Micron turning down pre-market (memory chain sentiment backfire); PMI (released 9:30) significantly below expectations triggering macro selling; unusual moves in treasury futures.
• Macro watch: 9:30 official PMI (manufacturing consensus near the prior reading around 49.x, to be released); only RMB 8 billion of OMO maturing today, liquidity fine; pre-holiday cash-out selling concentrated after 14:30.

---

9. Final Recommendations

① Today's 5 Most Worthy Stocks

Note: the Top 5 is a subjective selection balancing branch coverage, realization path, and trading attributes — not a pure score output; the pure score ordering is in the Section 3 leaderboard.

② Today's 3 Strongest Branches (aligned with Section 2 ordering)

③ Directions Not to Chase Today

• Publishing / media follow-through: Xinhua Media's own risk warning after 6 boards (209x PE); the high-leader cluster enters the faith stage — watch, don't touch;
• Solid-state theme elasticity: the 20cm impulse type like Shangshui Intelligent (H1 net profit -76%, no mass-production orders) — terrible odds chasing highs;
• Tankers / oil & gas: Brent -2.56% overnight, US-Iran easing warming, the reverse already triggered — don't pick it up before the holiday;
• High consecutive-board cohort: Xuelong Group (denial announcement already out), Shenzhen Property A, Xiangyang Bearing etc. — the just-repaired relay ecology doesn't support high-position relay;
• Memory / optical modules: Micron's earnings only land in the early hours of 10/1; large two-way volatility; poor odds holding through the holiday;
• GAC opening-day game: observe only, no re-entry.

④ Final One-Line Judgment

On the last pre-holiday trading day, cross-quarter liquidity is worry-free (the PBoC injected a net RMB 93 billion yesterday, with only RMB 8 billion maturing today), but volume must shrink; the main script is divergence and differentiation in the new mainlines — today observe only the three points that have "announcements, cash, and earnings": the pricing of Dizal Pharma's US$600 million receipt, Binjiang / Vanke absorption amid the property divergence, and the stability of the compute earnings anchor before the Micron earnings; if the auction gives no premium (Dizal opens flat or lower, Vanke no premium, GAC sealed orders collapse), then play defense all day into the holiday.

---

⚠️ Data sourcing and verification log (credibility notes for this report):

• Overnight US stocks 9/29 (US Eastern Tuesday) close and commodity data were taken from Jingwei's (中新经纬) 9/30 wire (grabbed via the NetEase repost page): Dow 51349.92/-0.26%, S&P 7670.84/-0.17%, Nasdaq 26797.54/-0.09%, SK Hynix +2%, Micron +1%, Apple -2.66%, Golden Dragon -1.55%, Brent 102.59/-2.56%, COMEX gold 4215/+1.12%, consistent with Eastmoney's "Overnight Markets" snapshot.
• A50 night-session caliber: this report's "+0.15% at 13,900 points" comes from Cailianshe's 9/30 wire; yesterday's report's "13,923 points (-0.01%)" was a 9/29 05:29 telegram (the previous trading night's session); the two figures belong to different trading sessions and are not to be read as a chained comparison. This A50 figure was verified only against the single Cailianshe source; no second cross-check (the Eastmoney futures page grab failed).
• PBoC OMO: net injection of RMB 93 billion on 9/29 (RMB 90.5 billion 7-day + RMB 698.5 billion overnight - RMB 66.1 billion overnight maturing - RMB 3.5 billion 7-day maturing), sourced from Shanghai Securities News / China Securities Network (republished by Economic Observer / Eastmoney); today's (9/30) OMO operation announcement is only released around 09:20, unavailable pre-market, so the body only says "only RMB 8 billion maturing."
• Dizal Pharma (迪哲医药): the US$600 million upfront receipt was verified via the company's 9/29 announcement (as relayed by Yicai / Phoenix Finance); the total deal value of US$1.5 billion (US$600 million upfront + up to US$900 million milestones + royalties) was verified via Zhitong Caijing / Yiyaomofang; the first-line sNDA FDA acceptance (8/30) was verified via 10jqka; financial data was cross-verified by fundamentals-analyst using akshare / Tencent quotes / Sina financial reports. PE (TTM) is negative; the body gives no specific multiple.
• The property policy (item 2) was released during the 9/29 intraday-to-post-close window (Caixin, 9/29); strictly speaking part of it falls within yesterday's time window; this report labels it "policy continuation" and counts it in today's branch-fermentation logic, and does not treat it as a brand-new pre-market positive.
• OpenAI dots: the source is Pasquale Pillitteri's Chinese site relaying OpenAI's official tweets and the DevDay talk; the primary OpenAI materials were not directly checked; it has been downgraded to "media report." Huawei Ascend 950 "begins service today" comes from a Toutiao morning-finance roundup (9/29); no first-hand Huawei source was obtained; the body marks it "awaiting official confirmation."
• Shangshui Intelligent board-count correction: yesterday's recap called it "20cm 2 consecutive boards"; verified against Tencent K-line that 9/28 closed RMB 42.85 (-3.95%) and 9/29 closed RMB 51.42 (+20% limit-up), so it should be the first 20cm board; the body has been rewritten per the K-line.
• Dragon-Tiger 9/29: Vanke A (Shenzhen Connect bought RMB 119 million / sold RMB 59.48 million, institutions net sold RMB 29.2 million, northbound net bought RMB 60 million) from Cailianshe / Securities Star; Gotion High-tech (Guotai Haitong Taiping South Road bought RMB 212 million) from Cailianshe's midday limit-up analysis. The exchange's full Dragon-Tiger details were not checked one by one.
• Vanke's interest-bearing debt aggregates to ~RMB 334 billion by report line items; the 2025 annual report disclosure caliber is RMB 358.48 billion; the difference is the lease-liability / accrued-interest caliber; the body uses the interim-report caliber of "interest-bearing debt due within one year ~RMB 154 billion vs RMB 59 billion cash."
• Fundamentals of all 8 stocks (Dizal / Vanke / Binjiang / Shangshui / China Publishing / Wangsu / Shenzhen Property / Cinda) were cross-verified by fundamentals-analyst with akshare + Tencent quotes + periodic reports; GAC / Xinlian / Gotion / Shengyi reused the verified data from the 9/29 pre-market report, spot-checked consistent.
• Today's IPO: 10jqka's IPO platform shows "one new listing on September 30"; the name was not verified to an authoritative source pre-market, so it is not included in the body.

⚠️ Risk warning: this list is only a pre-market information summary and watchlist, and does not constitute investment advice. A-share volatility risk is extremely high; automatically generated content may suffer from information timeliness gaps or industry-chain mapping errors, and must not be used directly as a trading basis. External variables are dense during the National Day holiday (Micron earnings, the US-Iran situation, US Treasury yields, overseas macro data); a gap risk exists at the post-holiday open; holding positions through the holiday requires a careful assessment of your own risk tolerance.